
Ibyra (Olaparib 150mg Tablets) is a targeted therapy used to treat ovarian, breast, pancreatic, and prostate cancers with BRCA gene mutations. It works by blocking cancer cell repair, slowing their growth.
| Composition | Olaparib |
| Manufacturer | Zydus |
| Packing | 60 Tablets |
| Prescribed For | Ovarian, Breast, Pancreatic, Prostate cancer |
| Expiry | December 2027 |




Order Ibyra (Olaparib 150mg Tablets, Lynparza) at competitive prices from our licensed and reliable generic pharmacy. We are a trusted pharmaceutical wholesaler and global exporter, supplying premium-quality, approved generic oncology medicationss in bulk to patients, hospitals, doctors, clinics, and healthcare professionals across 80+ countries, including Colombia, Venezuela, Panama, Peru, the Philippines, Ecuador, Namibia, Cyprus, Egypt, Iran, South Africa, Zimbabwe, Bahrain, Iraq, Israel, Saudi Arabia, the UAE, Jordan, Palestine, Qatar, China, Malaysia, Singapore, Vietnam, Canada, Brazil, Mexico, Russia, Thailand, South Korea, Taiwan, Indonesia, the United States, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
Special pricing and offers available for bulk or long-term prescription purchases.
We source medicines directly from certified pharmaceutical manufacturers.
We support reshipments or refunds for undelivered, damaged, or incorrect orders.
Place your order through our website, WhatsApp, email, or by calling from anywhere in the world.
We coordinate with prescribing doctors (if needed) to ensure proper compliance and safety.
Customer care is available in English, Spanish, Russian, and other regional languages to assist global clients.